Amgen to terminate participation in co-development and commercialization of brodalumab

Go back to Amgen to terminate participation in co-development and commercialization of brodalumab
Amgen Inc (NASDAQ: AMGN) Delayed: 410.24 +17.08 (4.34%)
Previous Close $393.16    52 Week High $176.85 
Open $405.25    52 Week Low $133.64 
Day High $413.00    P/E 61.78 
Day Low $398.52    EPS $6.64 
Volume 3,720,925       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 2,306,257       

Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 18.04 +0.03 (0.17%)
Previous Close $18.01    52 Week High $18.64 
Open $18.12    52 Week Low $12.59 
Day High $18.17    P/E N/A 
Day Low $18.04    EPS $0.00 
Volume 25,829